Grail (GRAL) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

GRAL Grail

Watchlist

55.020
+2.440+4.64%

Close Feb 14 16:00 ET

57.000
+1.980+3.60%

Post 20:01 ET

1.85BMarket Cap-0.86P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Selling US$3.6m Of Stock Was Lucrative Decision For GRAIL Insiders
Simply Wall StFeb 16 09:10 ET
Earnings Preview: Grail to Report Financial Results Post-market on February 20
Moomoo NewsFeb 16 03:15 ET
Grail Rallies 30% in Wake of Quest Agreement
Seeking AlphaFeb 13 15:49 ET
Grail Distribution Partnership With Quest a Positive, Says Guggenheim
TipRanksFeb 13 08:06 ET
GRAIL to Announce Fourth Quarter 2024 Financial Results
PR NewswireFeb 12 16:02 ET
Grail Shares Spiked Wednesday: What's Going On?
BenzingaFeb 12 15:58 ET

Comments

别叫我买股票

Feb 11 10:56

$Grail (GRAL.US)$ garbage

Jaguar8

Jan 22 23:28

🟤 Watchlist, JANUARY 23,2025, Thursday. NFA

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
8. With regards t...

frogoracletrading

Aug 13, 2024 15:34

$GRAL Support / Resistance Levels

Here are the levels to watch on this move up.
Larger Image: tradingview.com...
$Grail (GRAL.US)$

Jaguar8

Jul 15, 2024 02:57

NEWS

$Grail (GRAL.US)$
GRAIL Advances the Galleri® Registrational Clinical Trial Program
GRAIL (NASDAQ: GRAL) has announced significant progress in its clinical trials for the Galleri® multi-cancer early detection (MCED) test. The company has completed enrollment of over 35,000 participants in the PATHFINDER 2 study across North America and finished the final study visits for the NHS-Galleri trial with more than 140,000 participants in England. Results from the first 25,000 PATHFINDER 2 participan...

MomentumPython1337

Jun 25, 2024 09:46

the botched acquisition of Grail is over

$Illumina (ILMN.US)$ botched the acquisition of $Grail (GRAL.US)$ after the move was banned by european authorities and has finished divesting as GRAL just opened shop on stock markets very recently as a separate entity from ILMN. with this shareholders might start to pour money back into Illumina which is clearly undervalued by any metric you throw at it it's not a dead business so there's some money to be made here you can look at the chart recently ...

Trending Stocks

Symbol Mini Chart % Chg

DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS

Unlock the Full List